Framework-shuffling of antibodies

Details for Australian Patent Application No. 2006227377 (hide)

Owner Medimmune, Inc.

Inventors Dall'acqua, William; Wu, Herren; Damschroder, Melissa

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006227377

PCT Pub. Number WO2006/102095

Priority 60/662,945 18.03.05 US; 60/675,439 28.04.05 US

Filing date 17 March 2006

Wipo publication date 28 September 2006

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 16/44 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material not provided for elsewhere

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/102095 Priority application(s): WO2006/102095

2 October 2008 Alteration of Name

  The name of the applicant has been altered to MedImmune, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006227379-Synthesis of avrainvillamide, stephacidin B, and analogues thereof

2006227372-Precision-folded, high strength, fatigueresistant structures and sheet therefor